shame on anybody for depending on david sobek's analysis of a biotech with these credentials, from his 'seeking alpha' bio:
'I have a PhD in political science and have been investing for well over a decade. I generally follow small cap biotechnology, MLPs, and mining companies. I hope to provide my thoughts on both topics of interest to investors and particular companies.'
i've followed biotechs for 15 years, and i'm no expert, ...either.
Dew...that's really stretching it, even for you. in fact, it's an absurd reference for this board.
I am long pphm. i respect most of what's on this board, but there is definitely a stench of bias that diminishes all the good stuff here.
people here want pphm pumpers to see the facts and acknowledge them. most of us do both. not many people residing here do not!.
yeah, lots of folks have lost a bundle on Peregrine, lots are up big over time....just like with all biotechs.
apparently, the FDA thought the 11.7 survival might have been a valid number based on contracted, 3rd party results.
if i or my family members or friends were facing this scourge of a disease, i think i'd be taking a look at it when considering options.
you can gloat when it fails P3. till then, it may be wiser to tone it down.
how long till this is deleted?